Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 309-311, February 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soodsma, J. F.
Right arrow Articles by Snyder, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soodsma, J. F.
Right arrow Articles by Snyder, F.

The Biocleavage of Alkyl Glyceryl Ethers in Morris Hepatomas and Other Transplantable Neoplasms1

James F. Soodsma2, Claude Piantadosi3 and Fred Snyder

Medical Division, Oak Ridge Associated Universities,4 Oak Ridge, Tennessee 37830

This study compares the ether-cleaving ability of normal rat liver homogenate with various transplantable tumor homogenates. The results show that the cleavage system is the most active in normal rat liver and Morris Hepatoma 7794A, much less active in Hepatoma 7777, and very low or absent in the other tumors tested. These data demonstrate that neoplasms that contain high levels of O-alkyl-diacylglycerols do not have an active alkyl ether cleavage system.

1 This work has been supported in part by the American Cancer Society Grant P-470, and NIH Grant GM12562-06.

2 U. S. Atomic Energy Commission Postdoctoral Fellow.

3 School of Pharmacy, University of North Carolina, Chapel Hill, N. C. 27515.

4 Under contract with the U. S. Atomic Energy Commission.

Received 4/24/69. Accepted 6/19/69.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
H. Zheng, R. I. Duclos Jr., C. C. Smith, H. W. Farber, and R. A. Zoeller
Synthesis and biological properties of the fluorescent ether lipid precursor 1-O-[9'-(1''-pyrenyl)]nonyl-sn-glycerol
J. Lipid Res., March 1, 2006; 47(3): 633 - 642.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.